PRO57 COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2387
https://www.valueinhealthjournal.com/article/S1098-3015(19)34765-5/fulltext
Title :
PRO57 COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34765-5&doi=10.1016/j.jval.2019.09.2387
First page :
Section Title :
Open access? :
No
Section Order :
12084